Galenical formulations of Aliskiren

Details for Australian Patent Application No. 2008303504 (hide)

Owner Novartis AG

Inventors Meyer, Andreas; Busies, Heiko; Bianchi, Jean-Claude

Agent Davies Collison Cave

Pub. Number AU-B-2008303504

PCT Pub. Number WO2009/040373

Priority 60/975,894 28.09.07 US

Filing date 24 September 2008

Wipo publication date 2 April 2009

Acceptance publication date 22 March 2012

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/040373 Priority application(s): WO2009/040373

22 March 2012 Application Accepted

  Published as AU-B-2008303504

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008303511-A device for clamping two portions of a braid and an intervertebral implant comprising a spacer, a braid, and such a clamping device

2008303493-Architectural closure panel that collects solar energy and a movable solar energy collector roof